PNAA
AGN

Pictet North America Advisors’s Allergan Inc AGN Stock Holding History

Pictet North America Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,953
Closed -$242K – 65
2014
Q1 		$242K Buy
+1,953
New +$238K 0.07% 58

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pictet North America Advisors's AGN Position: Q2 2014 in Review

Pictet North America Advisors sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 1,953 shares — an estimated $242K sold.

Pictet North America Advisors first reported a position in AGN in Q1 2014 and held it in 1 quarter. The position peaked at $242K in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Pictet North America Advisors reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Pictet North America Advisors sold 1,953 Allergan Inc shares in Q2 2014, an estimated $242K.
  • Pictet North America Advisors first reported a position in Allergan Inc in Q1 2014 and held it in 1 quarter.
  • Pictet North America Advisors's Allergan Inc position peaked at $242K in Q1 2014.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Pictet North America Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.